2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit
02-03

October 2018

Austria

Vienna

Hilton Garden Inn Vienna South

Hertha-Firnberg-Straße 5, 1100

Co-located with Immuno-Oncology & Dx

We are pleased to invite you to the 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit scheduled for October 2nd 3rd, 2018 in Vienna, Austria. This Summit is co-located with Immuno-Oncology & 4th Annual Biomarkers - CDx - Precision Immunotherapy Summits. The co-located Summits will bring together decision makers and industry leaders with both scientific and commercial interests to expand the scientific horizons of Biomarkers, Precision Medicine, Companion Dx, Immuno-Oncology and Microbiome, and will shed the light...

We are pleased to invite you to the 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit scheduled for October 2nd 3rd, 2018 in Vienna, Austria. This Summit is co-located with Immuno-Oncology & 4th Annual Biomarkers - CDx - Precision Immunotherapy Summits. The co-located Summits will bring together decision makers and industry leaders with both scientific and commercial interests to expand the scientific horizons of Biomarkers, Precision Medicine, Companion Dx, Immuno-Oncology and Microbiome, and will shed the light on the latest advancements and improvements in research and development, business opportunities in partnering, and investment. We will discuss key findings, critical insights, as well as recommendations for accelerating development in the field. We are excited to be hosting these Summits in Vienna and we look forward to welcoming you in October.

more info
Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, and Managers specialising in:

  • Microbiome/Microbiota
  • Microbiology
  • Computational biology
  • Autoimmune Disease
  • Infectious Diseases
  • Inflammation
  • Food/Nutrition Science
  • Genotyping
  • Biomarkers
  • Data Management
  • Metagenomics
  • High-Throughput Screening
  • Diagnostic & Clinical Applications
  • Licensing or Technology Transfer
  • Regulatory
  • Clinical trials
  • Bacteria / Fungi / Viruses
  • Molecular Biology
  • Molecular Diagnostics
  • Immuno-oncology
  • Metabolic Disease
  • Vaccines
  • Neurodegeneration / Gut-Brain Axis
  • Genomics
  • Bioinformatics
  • Epigenetics
  • NGS
  • Personalized / Targeted Therapeutics
  • Venture Capitalists
  • Business Development/In-Licensing
  • Market Access
Key Practical Learning Points of the Summit

Emerging science and technologies for successful microbiome discovery and translation
Clinical applications of microbiome in oncology and beyond
Commercialisation and investment perspectives of microbiome – based diagnostics and therapeutics
Regulatory compliance for microbiome drugs
Translation of microbiome products:
Into clinical trials
For healthy nutrition
Into personalised therapeutics and diagnostic
Speakers
Dr. Frédéric Baribaud, US

Scientific Director

Janssen R&D

Dr. Shahram Lavasani, SE

Founder & CEO

ImmuneBiotech AB

Dr. Barbara Joyce-Shaikh, US

Project Leader, Discovery Research

Merck Research Laboratories

Dr. Oliver Chao, FR

Head, Emerging Biomedical Sciences Strategy & Innovation

Sanofi

Dr. Bram Vanparys, NL

Investment Director, Healthcare

Merck Ventures B.V

Dr. Hassan Benameur

Senior Director Oral Drug Delivery Innovation, Global Pharma Biotech R&D

Lonza Biologics plc

Dr. Olga Sakwinska, CH

Nestlé Institute of Health Sciences

Nestlé Research Center

Dr. Colette Shortt, UK

Consumer Fellow, Regulatory Director

J&J Consumer

Dr. Kristin Wannerberger, CH

Director Alliance Management R&D

Ferring Pharmaceuticals

Dr. Audrey Gueniche, FR

Clinical Scientific Coordinator / Senior Expert, Advanced Research

L’Oréal Research & Innovation

Dr. Jean de Gunzburg, UK

Chief Scientific Officer

Da Volterra

Dr. Gregory Lambert, FR

CEO – VP R&D

TargEDys SA

Dr. Patrice Garnier, FR

Chief Executive Officer

Amabiotics

Dr. Ylaine Gerardin, US

Data Scientist

Finch

Dr. Imke Mulder, UK

Research Director

4D Pharma Research Ltd.

Dr. Gianluca Ianiro, IT

Digestive Disease Center

IRCCS Fondazione Policlinico Universitario ‘A. Gemelli’, Rome

Dr. Morten L. Isaksen, NO

Founder & CEO

Bio-Me AS

Annual

Events

Sponsors and Partners

Sponsor

Sponsor

Partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

"